Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the

Christina Lalani1, Ravi K Sharma2, Jonathan Sevilla-Cazes3

  • 1Division of Cardiology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Insights

Transcatheter aortic valve replacement (TAVR) patients undergoing percutaneous coronary intervention (PCI) had similar procedural success but higher risks of stroke, bleeding, and repeat PCI compared to non-TAVR patients. These findings highlight potential challenges in coronary access post-TAVR.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Health Services Research

Background:

  • Transcatheter aortic valve replacement (TAVR) devices may complicate coronary artery access.
  • Limited real-world data exist comparing percutaneous coronary intervention (PCI) outcomes in post-TAVR versus non-TAVR patients.

Purpose of the Study:

  • To compare procedural characteristics and outcomes of PCI in patients with and without a history of TAVR.
  • To evaluate the incidence and outcomes of PCI following TAVR in a real-world setting.

Main Methods:

  • Utilized Medicare claims data (2011-2017) to assess PCI incidence post-TAVR.
  • Employed the CathPCI Registry to compare PCI outcomes between 1,309 post-TAVR patients and 5,236 propensity score-matched non-TAVR patients.

Main Results:

  • Procedural success for PCI was similar between post-TAVR and non-TAVR groups.
  • Post-TAVR patients experienced longer fluoroscopic times (21.9 vs 17.7 min) and higher rates of post-procedural stroke (0.8% vs 0.4%) and bleeding (5.1% vs 2.9%).
  • Post-TAVR patients had increased likelihood of repeat PCI (HR: 1.36), stroke (HR: 1.65), and death (HR: 1.23) within 3 years post-PCI.

Conclusions:

  • PCI in patients with a TAVR history shows similar procedural success but increased procedural complexity and adverse events.
  • Higher rates of stroke, bleeding, and repeat PCI necessitate careful consideration in post-TAVR patients requiring coronary intervention.
  • Findings underscore the importance of managing coronary access and outcomes in the TAVR population.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...